Biography
Elizabeth Chang is an associate in the Firm's Los Angeles office and is a member of the Intellectual Property Practice Group. Elizabeth's practice focuses on counseling market-leading life sciences, pharmaceutical, biotech, and medical device companies in their intellectual property matters with a focus on patent disputes. Elizabeth has helped clients navigate lawsuits arising under the Hatch-Waxman Act and Biologics Price Competition and Innovation Act (BPCIA), appeals to the United States Court of Appeals for the Federal Circuit, and proceedings before the USPTO. Her experience includes initial assessment of claims and defenses, motions practice, discovery, claim construction, participating in and conducting depositions, and participating in oral argument at hearings before district courts and the Federal Circuit. Elizabeth also assists with patent litigation risk assessments, patent evaluations, and IP due diligence reviews.
During law school, Elizabeth was an extern for U.S. District Court Judge James V. Selna, a patent pilot judge of the United States District Court for the Central District of California. Elizabeth also worked as an extern for Sacramento Superior Court Judge David De Alba. At U.C. Davis, Elizabeth was the Senior Notes and Comments Editor of the UC Davis Law Review and received the Patrick Hopkins Memorial Writing Award for writing an exceptional Law Review Note or Comment.
Prior to law school, Elizabeth worked as a research specialist at the Sue & Bill Gross Stem Cell Research Center at the University of California, Irvine researching and developing antibody and aptamer-based drugs for the treatment of cancer.
Elizabeth holds a degree in engineering, with a focus on bioengineering, from Dartmouth College and a degree in physics from Colby College.
Experience
Representative Experiences:
- Counsel for Vertex Pharmaceuticals in Hatch-Waxman litigation concerning the cystic fibrosis drug KALYDECO® (D. Del.)
- Counsel for Pfizer in patent infringement litigation brought against its RSV vaccine ABRYSVO® (D. Del.)
- Counsel for Myriad Genetics in patent infringement litigation brought against its PREQUELTM brand prenatal screen (D. Del.).
- Counsel for Anacor Pharmaceuticals in Hatch-Waxman patent infringement litigation against several defendants brought to protect Anacor's EUCRISA® brand product (D. Del.).
- Counsel for Pfizer in BPCIA patent infringement litigation (D. Del.) and PTAB proceedings concerning Pfizer's NYVEPRIATM (pegfilgrastim) biosimilar.
- Counsel for Pfizer in BPCIA patent infringement litigation concerning Pfizer's NIVESTYM® (filgrastim) biosimilar (D. Del.).
- Counsel for Wyeth and Pfizer in Federal Circuit appeals from inter partes review proceedings concerning pneumococcal vaccine technology.
- Counsel to Pfizer in a Federal Circuit appeal from an inter partes review proceeding concerning protein-purification patents.
- Counsel to Pfizer in proceedings under the BPCIA concerning the biosimilar drugs ZIRABEV® (bevacizumab-bvzr) and RUXIENCE® (rituximab-pvvr).
Chang, Elizabeth K., et al. "Facile supermolecular aptamer inhibitors of L-selectin." PLoS One 10.3 (2015): e0123034.
Co-author on Zhang, Zhiqing, et al. "DNA‐Scaffolded Multivalent Ligands to Modulate Cell Function." ChemBioChem 15.9 (2014): 1268-1273.
Co-author on Kang, Dong-Ku, et al. “Microfluidic devices for stem cell analysis.” Microfluidic Devices for Biomedical Applications, 388. Woodhead Publishing (2013).